Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$38.26
+2.00%
Mkt Cap $2.46B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (15 analysts)
$53.80
Range $42.00 – $74.00
Implied Upside
+40.6%
Consensus $53.80 vs current $38.26
NASDAQ·Healthcare·Biotechnology
$38.26
+2.00%
Mkt Cap $2.46B
Buy
13
Hold
0
Sell
0
Price Target (15 analysts)
$53.80
Range $42.00 – $74.00
+40.6%
Consensus $53.80 vs current $38.26